Trials / Completed
CompletedNCT00658606
Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects
Efficacy and Safety of Alefacept in Combination With Narrow-band UVB (nbUVB) Compared to Alefacept Alone in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 98 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Assess the efficacy and safety of alefacept with nbUVB compared to alefacept alone in chronic plaque psoriasis subjects. Combination therapy may improve the clinical response to psoriatic subjects as both modalities have an effect on T cells
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | alefacept | IM |
| PROCEDURE | Narrow Band UVB Phototherapy | UVB Phototherapy |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2008-04-15
- Last updated
- 2013-01-08
- Results posted
- 2011-04-22
Locations
12 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00658606. Inclusion in this directory is not an endorsement.